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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.08.039Objective: The International Society for Heart and Lung Transplantation has pro-
posed a new grading system for primary graft dysfunction based on the ratio of
arterial oxygen to fraction of inspired oxygen measured within 48 hours after lung
transplantation. Worsening primary graft dysfunction grade is associated with
increased operative mortality rates and decreased long-term survival. This study
evaluated donor and recipient risk factors for postoperative International Society for
Heart and Lung Transplantation grade 3 primary graft dysfunction.
Methods: We reviewed donor and recipient medical records of 402 consecutive lung
transplantations performed between 1992 and 2004. We calculated a worst Inter-
national Society for Heart and Lung Transplantation primary graft dysfunction
grade in the first 48 hours postoperatively. Severe primary graft dysfunction (In-
ternational Society for Heart and Lung Transplantation grade 3) was defined by a
ratio of arterial oxygen to fraction of inspired oxygen of less than 200. Associations
of potential risk factors with grade 3 primary graft dysfunction in the first 48 hours
postoperatively were examined through bivariate and multivariate analysis.
Results: The 90-day mortality rate associated with the development of International
Society for Heart and Lung Transplantation grade 3 primary graft dysfunction in the
first 48 hours postoperatively was 17% versus 9% in the group without grade 3
primary graft dysfunction. Significant bivariate risk factors associated with this end
point were increasing donor age, donor smoking history of more than 10 pack-years,
early transplantation era (1992-1998), increasing preoperative recipient pulmonary
artery pressure, and recipient diagnosis. In the multivariate analysis only recipient
pulmonary artery pressure, donor age, and transplantation era were associated with
grade 3 primary graft dysfunction in the first 48 hours postoperatively at a P value
of less than .05.
Conclusions: Our analysis of donor and recipient risk factors for severe primary
graft dysfunction identified patient groups at high risk for poor outcomes after lung
transplantation that might benefit from treatments aimed at reducing reperfusion
injury.
Transplantation is the only effective treatment for several end-stage lungdiseases. However, the outcomes of patients after a lung transplantationprocedure are poor when compared with those after transplantation of other
solid organs. Early mortality rates approach 15% in most series, and 3-year patient
survival rates are approximately 50%. Predictors of 90-day mortality, including poor
early graft function (ischemia-reperfusion injury or primary graft dysfunction
[PGD]), have been identified.1 Reported 30-day mortality rates of patients with
severe PGD are nearly 8 times as high as those for patients without severe PGD.2
A classification system for PGD based on the measured partial pressure of arterial
oxygen to fraction of inspired oxygen ratio (P/F ratio) has recently been proposed
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tation (ISHLT) working group.3 It has many features in
common with the American European Consensus Confer-
ence definition of acute respiratory distress syndrome.4 Pa-
tients with the most severe PGD grade (ISHLT grade 3)
have decreased perioperative survival, an increased rate of
perioperative complications, and an increased length of
hospital stay.1-3 Other measures of PGD, such as oxygen-
ation index or lung compliance, might have added prognos-
tic utility, but these have not been validated in reports of
large series of patients.5-11
The purpose of this study was to identify donor and
recipient characteristics that were associated with the devel-
opment of ISHLT grade 3 PGD in the first 48 hours after
lung transplantation.
Methods
Patients
The Institutional Review Board at the University of Minnesota
approved this study. Charts of all patients undergoing a lung
transplantation procedure from January 1, 1992, through Decem-
ber 31, 2004, were reviewed. Information about the respective
donors was also collected. Those patients who underwent living
donor lobar transplantation and those who received heart-lung
transplants were excluded from analysis. The donor characteristics
examined were demographics, cause of death, cytomegalovirus
(CMV) exposure, days on the ventilator before retrieval of the
organs, bronchoscopic findings, Gram stain and culture results,
blood gas analysis, and graft ischemic times. Recipient character-
istics examined were demographics, preoperative hemodynamics,
comorbidities, CMV status, pulmonary function tests, whether
cardiopulmonary bypass was used for the operation, and the pres-
ervation solution used for the organs. During the procurement, low
tidal volume ventilation was used. Initially, prostaglandin E is
administered to donors. Next, the pulmonary arteries are cross-
clamped and donor lungs are then antegradely perfused. After
donor lung implantation, the crossclamps are removed over a
5-minute period. This approach was consistent throughout the
series.
Transplant Criteria and Immunosuppression
The lung transplantation protocol at our institution, including
details of organ retrieval, operative technique, and postoperative
Abbreviations and Acronyms
BLT  bilateral lung transplantation
CMV  cytomegalovirus
ISHLT  International Society for Heart and Lung
Transplantation
P/F ratio partial pressure of arterial oxygen to
fraction of inspired oxygen ratio
PGD  primary graft dysfunction
SLT  single-lung transplantationimmunosuppression, has been previously reported.12-14 The ma-
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nisone, and azathioprine; however, the substitution of newer im-
munosuppressants, such as mycophenolate mofetil and tacrolimus,
to the regimen of some recipients took place during the time period
under review. Induction therapy was not used in our program
during the study period.
At our institution, we have only offered transplantations to
patients younger than 65 years of age at the time of their first
evaluation. Other relative contraindications include significant
concurrent medical illnesses (ie, hepatic disease with portal
hypertension or coronary artery disease) that would limit sur-
vival, rehabilitation, or both; chronic high-dose steroid use
(20 mg of prednisone per day); and a diagnosis of a rheuma-
tologic disease.
Assignment of ISHLT PGD Grades
Patients were assigned to PGD grades 1 through 3 on the basis of
guidelines issued by a 2004 ISHLT working group conference on
the subject (Figure 1). We made 2 changes to the ISHLT grading
system for the purposes of our analysis (Table 1). First, the original
grading system proposed including a fifth time point for grading
PGD severity 72 hours after transplantation (T72). Second, any
patient with a P/F ratio of greater than 300 was classified as having
grade 1 PGD. We did not analyze their chest radiographs for the
presence or absence of infiltrates. Time points chosen for analysis
were at intensive care unit arrival (T0) and 12 hours (T12), 24
hours (T24), and 48 hours after transplantation (T48). The worst
grade at T(0-48) reflected the most severe grade recorded during
the 48-hour period.
Only analysis of the 48-hour worst grade data from our
institution showed that the development of modified IHSLT
grade 3 PGD was associated with increased perioperative mor-
tality rates and decreased long-term survival (Figure 1, B , for
perioperative mortality and Figure 2 for long-term surviv-
al).15,16 As a result of this finding, patients were stratified into
2 primary outcome groups for study: those who did and those
who did not have modified ISHLT grade 3 PGD within the first
48 hours after the transplantation. To be placed in the favorable
group on the basis of extubation (one of the definition’s crite-
ria), the patient had to remain extubated for 48 hours. Patients
requiring extracorporeal membrane oxygenation support (23/
402 [6%] of patients) were automatically classified as having
grade 3 PGD.
Statistical Analysis
Donor-related and patient-related characteristics were analyzed for
their association with the development of modified ISHLT grade 3
PGD within the first 48 hours after transplantation (severe PGD
group). These bivariate associations were tested for statistical
significance by using either the Pearson 2 test for nominal and
ordinal data or the independent sample t test for continuous vari-
ables. Analyses were performed with SAS for Windows, Version
9.1 (SAS Institute Inc, Cary, NC).
Donor and patient characteristics that were statistically signif-
icantly related to severe PGD (P  .100) were tested for inclusion
in the final multivariate analysis. Multivariate logistic regression
was used to adjust for potential confounding. Characteristics were
introduced stepwise in the following order: demographic and per-
ry 2006
Whitson et al General Thoracic Surgery
G
TSsonal characteristics, pulmonary arterial pressures/ISHLT grade,
and donor characteristics. The final model included donor and
patient characteristics that were independently and statistically
associated (P  .05) with severe PGD. Final results were ex-
pressed as multivariate odds ratios and 95% confidence intervals.
The odds ratios can be interpreted as the increased or decreased
odds of grade 3 PGD, with those with the characteristic compared
with the odds of the event in those without the characteristic (the
reference category). The c-statistic was used to measure the dis-
crimination of the final model. Values approaching 0.70 or greater
were considered the minimum necessary for a sound model. The
Hosmer-Lemeshow test for goodness of fit was used to measure
the calibration of the final model. A statistically nonsignificant 2
test result is accepted for adequate agreement between the ob-
Figure 1. Prevalence and 90-day survival of patients with grade 3
primary graft dysfunction (PGD). A, Point prevalence of Interna-
tional Society for Heart and Lung Transplantation grade 3 PGD at
each individual time during the first 48 hours is represented by
the open bars. The cumulative percentage of grade 3 prevalence
is shown in the filled bars. B, Percentage of patients dying within
90 days after surgical intervention stratified by whether (filled
bars) or not (open bars) the patient had grade 3 PGD at each time
point after the operation and as a worst grade 48-hour end point
(last set of bars). The differences in 90-day death rates among
groups were significantly different (P < .05, 2 test) at all time
points.served and expected events.17
The Journal of ThoracResults
Demographics
During the 13-year study period, we performed 402 lung
transplantation procedures from cadaveric donors (Table 2);
256 (64%) patients underwent single-lung transplantation
(SLT), and 146 (36%) underwent bilateral lung transplan-
tation (BLT). Eight (2%) patients (7 SLTs and 1 BLT)
underwent retransplantation. The mean recipient age at the
time of transplantation was 50  11 years (range, 7-68
years), and 46% were men. The indication to undergo
transplantation included chronic obstructive pulmonary dis-
ease (61%), idiopathic pulmonary fibrosis (12%), cystic
fibrosis (11%), primary pulmonary hypertension (6%), and
miscellaneous disorders (7%). Patients given diagnoses of
TABLE 1. Definitions of primary graft dysfunction grade
ISHLT PGD definition
Modified ISHLT
PGD definition
Grade 0 P/F ratio 300 CXR clear NA
Grade 1 P/F ratio 300 CXR infiltrate P/F ratio 300
Grade 2 P/F ratio 200-300 P/F ratio 200-300
Grade 3 P/F ratio 200 P/F ratio 200
Time points T0, T12, T24, T48, T72 T0, T12, T24, T48
Worst grade T(0-48) T(0-72) T(0-48)
ISHLT, International Society for Heart and Lung Transplantation; PGD,
primary graft dysfunction; P/F, partial pressure of arterial oxygen/fraction
of inhaled oxygen concentration ratio; CXR, chest radiograph; NA, not
applicable.
Figure 2. Long-term survival stratified by modified primary graft
dysfunction grade. Kaplan-Meier actuarial survival curves are
stratified by modified International Society for Heart and Lung
Transplantation (ISHLT) grade. Patients with grade 3 primary graft
dysfunction had a significantly reduced survival compared with
those with grade 1 and grade 2 primary graft dysfunction (median
survival grade 3, 4.6 years; grade 2, 6.6 years; grade 1, 7.5 years;
P  .006, log-rank test). Grade 1 is represented in dark dray,
grade 2 is represented in light gray with hatching, and grade 3 is
represented in black.
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monary fibrosis underwent SLT significantly more often
than BLT, whereas BLT was favored over SLT for other
causes of end-stage lung disease. Mean allograft ischemic
times were 245  62 minutes (range, 120-428 minutes) for
SLT and 357 90 minutes (range, 194-697 minutes) for the
second lung transplanted in the BLT pair (Table 2).
PGD Groups and Outcome
Grouping patients by the highest modified PGD grade (cor-
responding to the lowest P/F ratio) within 48 hours of the
operation yielded evenly distributed groups: 143 (38%)
patients with grade 0 to 1 PGD, 110 (30%) with grade 2
PGD, and 119 (32%) with grade 3 PGD. Similar numbers of
patients undergoing SLTs and BLTs had 1 or more P/F
measurements of less than 200 between T0 and T48 (87
SLTs, or 34%, and 53 BLTs, or 37%). The prevalence of
severe PGD decreased with time: 25% of patients had grade
3 PGD at T0, 21% at T12, 17% at T24, and 15% at T48.
However, the 90-day death rate associated with the occur-
rence of severe PGD at each time point increased with time
(Figure 1). At all time points and with the worst grade end
point, the development of grade 3 PGD was associated with
an increased rate of perioperative death when compared
with the group of patients who did not have grade 3 PDG.
The occurrence of severe PGD (modified ISHLT grade
3) within the first 48 hours after transplantation was also
associated with a decreased long-term survival (Figure 2).
Increasing preoperative pulmonary artery pressure, an SLT
TABLE 2. Patient demographics
Overall
(n  402)
SLT
(n  256)
BLT
(n  146)
Male sex (%) 46 45 47
Age (y) 50 11 55  7 41  10
Diagnosis (%)
COPD 61 76* 37
IPF 12 16* 3
CF 11 1* 30
PPH 6 1* 16
Other 9 7* 14
PA pressure (mm Hg)
Cath PA (mean) 25 11 23  7† 29  15
OR PA (mean) 27 11 25  7† 30  16
Ischemic time (min) 287 92 245 62† 357 90
Values are reported as percentages or as means  standard deviation.
SLT, Single-lung transplantation; BLT, bilateral lung transplantation; COPD,
chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis;
CF, cystic fibrosis; PPH, primary pulmonary hypertension; Cath PA, pulmo-
nary artery pressure measured by means of preoperative right heart
catheterization; OR PA, pulmonary artery pressure measured by means of
preimplantation Swan-Ganz catheter reading. *2 versus BLT. †t Test
versus BLT.procedure, and the need for cardiopulmonary bypass during
76 The Journal of Thoracic and Cardiovascular Surgery ● Januathe transplantation were other independent predictors of
these end points in this group of patients.16
Donor Characteristics
Reliable donor data were available on sex, age, height and
weight, year of transplantation, type of procedure, days on
ventilator, CMV status, mechanism of death, arterial blood
gases, smoking history, ischemic times, bronchoscopic find-
ings, and Gram stain results. All of these characteristics
were examined for their bivariate associations with the
development of severe PGD (Table 3). Donor age, a history
of smoking of greater than 10 pack-years, and a transplantation
occurring in the earlier era of the study (1992-1998) were
associated with the end point at a P value of less than .05.
Recipient Characteristics
Reliable recipient data were available on type of transplan-
tation, age, sex, height and weight, diagnosis, CMV status,
pulmonary function, comorbidities, preoperative and intra-
operative hemodynamics, need for cardiopulmonary bypass
during the transplantation, and the preservation solution
used for the procurement. All of these characteristics were
examined for their bivariate associations with the develop-
ment of severe PGD (Table 3). Only increasing preoperative
pulmonary artery pressure and recipient diagnosis were
associated with the end point at a P value of less than .05.
Multivariate Model
Donor and recipient characteristics associated with the de-
velopment of severe PGD in the respective bivariate models
were entered as potential risk factors in a multivariate
logistic regression model. The performances of the trans-
plantation in the earlier era of the study (1992-1998), in-
creasing donor age, and increasing recipient preoperative
pulmonary artery pressure were independently associated
with the end point of severe PGD (Table 4). A graphic
display of the multivariate adjusted odds of severe PGD
according to donor age and preoperative pulmonary artery
pressure is shown in Figure 3. There is an inflection of the
donor age risk curve at approximately 30 years of age and
in the pulmonary artery pressure curve at a mean pressure of
30 mm Hg.
Discussion
In our analysis of 402 lung transplant recipients at the
University of Minnesota from 1992 through 2004, we have
confirmed the effect of severe grade 3 PGD on short- and
long-term outcomes after lung transplantation. Its occur-
rence at any time point within the first 48 hours after
transplantation is associated with at least a 1.8-fold increase
in the risk of 90-day death. In this dataset the development
of severe PGD was associated with a poor early and late
outcome. These data will be reported elsewhere.
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Donor characteristics n
T (0-48)
grade 3 P value Recipient characteristics n
T (0-48)
grade 3 P value
Male sex Single-lung transplantation
Overall - Y 216 38% NS Y 256 35% NS
N 177 32% N 146 37%
SLT - Y 139 36% NS
N 111 33% Era
BLT - Y 77 43% NS 1992-1998 195 44% .0004
N 66 30% 1999-2004 199 27%
Age (32 y; median) PA pressure (mean)
Overall - Y 193 42% .0092 Overall - 20 131 31% .006
N 198 29% 21-29 155 37%
SLT - Y 132 43% .0014 30 96 42%
N 118 25% BLT - 20 40 35% .0009
BLT - Y 61 41% NS 21-29 46 33%
N 80 34% 30 49 45%
SLT - 20 91 29% .019
Smoking - 10 pack-years 21-29 109 39%
Overall - Y 75 47% 0.034 30 47 38%
N 281 33%
SLT - Y 47 43% NS CPB
N 187 34% Overall - Y 115 39% NS
BLT - Y 28 54% .048 N 274 34%
N 94 33% SLT - Y 30 47% NS
N 204 33%
Traumatic brain death BLT - Y 84 36% NS
Overall - Y 180 32% NS N 56 39%
N 211 39%
SLT - Y 113 30% NS Male sex
N 137 39% Overall - Y 180 32% NS
BLT - Y 67 34% NS N 214 38%
N 74 39% SLT - Y 111 32% NS
N 140 36%
Positive sputum Gram stain BLT - Y 69 32% NS
Overall - Y 142 38% NS N 74 42%
N 141 33%
SLT - Y 85 38% NS Age 53 y (median)
N 97 35% Overall - Y 197 35% NS
BLT - Y 57 39% NS N 191 37%
N 44 30% SLT - Y 180 36% NS
N 68 33%
BLT - Y 17 23% NS
N 123 39%
Diagnosis
Overall - COPD 243 31% .016
IPF 46 41%
CF 44 43%
PPH 24 63%
Other 36 36%
SLT - COPD? Y 191 34% NS
COPD? N 60 38%
BLT - COPD? Y 52 19% .0005
COPD? N 90 48%
Age and recipient pulmonary artery pressure were analyzed as continuous variables. NS, Not significant; SLT, single-lung transplantation; BLT, bilateral
lung transplantation; PA, pulmonary artery; CPB, cardiopulmonary bypass; COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis;
CF, cystic fibrosis; PPH, primary pulmonary hypertension.
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development of severe PGD is important for several rea-
sons. Their modification might be effective in reducing the
rate of development of severe PGD. Donor-recipient match-
ing might also be improved. Many centers have begun to
use marginal or extended donors after several reports sug-
gesting that the practice was not associated with excessive
early mortality rates.14,18-21 Pierre and colleagues,21 how-
ever, have recommended that caution be exercised in the
widespread application of these modified donor criteria,
which include donor age greater than 55 years, smoking
history of longer than 20 pack-years, bronchoscopic find-
ings of purulent secretions, the presence of infiltrates on the
chest radiograph, and a PO2 of less than 300 mm Hg. In our
series increasing donor age and smoking history were both
associated with increased rates of PGD, although the 10 pack-
year smoking history breakpoint did not achieve the level of
statistical significance in the multivariate model. The rate of
development of grade 3 PGD within the first 48 hours for the
26 patients in the series who received lungs from donors with
a greater than 20 pack-year history was 52%.
The transplantation of lungs from donors older than 50
years does appear to be associated with very high risks of
grade 3 PGD (Figure 3). In fact, the relationship between the
odds of development of grade 3 PGD and donor age in our
series is linear from about age 35 years upward, a trend very
similar to that found in the analysis of other series and of
ISHLT registry data with respect to longer-term mortality.3
The most favorable recipient outcomes seem to be associ-
ated with donors between 20 and 30 years of age.
Our program has been conservative with respect to our
acceptance of marginal donors by other criteria outlined by
Pierre and colleagues.21 Very few donors had arterial blood
gas PO2 values of less than 300 mm Hg, only 11% of donor
lungs had an infiltrate on the chest radiograph, and only 6%
TABLE 4. Results of multivariate logistic regression anal-
ysis of donor and recipient risk factors for primary graft
dysfunction
Estimate  SE
Estimated odds ratio
(95% confidence
interval)
P
value
Era (1999-2004) 0.32 0.12 0.47 (0.28-0.80) .047
Donor age 0.024 0.009 1.03 (1.01-1.05) .006
PA pressure (mean) 0.029 0.011 1.03 (1.01-1.05) .014
Diagnosis not COPD 0.21 0.12 NS
Smoking 10
pack-years
0.18 0.15 NS
For the variables analyzed continuously, the incremental changes associ-
ated with the additive risk are per year for donor age and per millimeter of
mercury for pulmonary artery pressure. SE, Standard error; PA, pulmonary
artery; COPD, chronic obstructive pulmonary disease.had significant purulent bronchoscopic secretions. None of
78 The Journal of Thoracic and Cardiovascular Surgery ● Januathese characteristics were significantly associated with the
development of grade 3 PGD in our series. A positive Gram
stain result was reported in 143 (49%) of 289 donors for
whom data were available. There was no difference in the
rate of development of grade 3 PGD among recipients
receiving lungs from a donor with a positive or a negative
Gram stain result, although the vast majority of these pa-
tients had only 1 gram-positive organisms identified on
the test.
Our analysis has several limitations. First, we choose to
analyze only one of many possible end points that reflect the
development of severe PGD in a patient after a transplan-
Figure 3. Adjusted odds of severe primary graft dysfunction
(PGD). A, Multivariate adjusted odds of PGD according to
donor age. Individual points represent the mean odds of groups
of 40 patients. The first data grouping was used as the refer-
ence. B, Multivariate adjusted odds of PGD according to pulmo-
nary artery (PA) pressure. Individual points represent the mean
odds of groups of 40 patients. The first data grouping was used as
the reference.tation. Other choices incorporating the 72-hour time mea-
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might have additional discriminate validity with respect to
early or longer-term patient outcomes. The optimal indica-
tor of PGD will likely be identified once the working group
definition is published and transplant centers have had the
opportunity to validate the predictive power of its various
components. Because severe PGD occurs with a greater
frequency than death and is associated with a poor short-
and long-term outcome, the analysis of this end point in
clinical care and in clinical trials is warranted. We believe
that because severe PGD is associated with a poor outcome,
the analysis of risks of severe PGD, rather than mortality,
would be more predictive.
In summary, the development of severe (modified
ISHLT grade 3) PGD is associated with a high operative
mortality and a poor long-term survival. The incidence of
severe PGD in our program has decreased over time. In a
multivariate analysis, additional risk factors for grade 3
PGD development within the first 48 hours after transplan-
tation (one measure of PGD) are (1) an increased preoper-
ative pulmonary artery pressure and (2) an increasing donor
age. Identification of at-risk patients and selective manage-
ment through altered strategies of ventilation to reduce
airway pressure, as in ARDS, or with -blockade to limit
perfusion, with pharmacologic agents to reduce ischemia-
reperfusion injury, or with extracorporeal membrane oxy-
genation to allow the lungs a period of low-perfusion re-
covery might ultimately improve the outcomes of patients
undergoing pulmonary transplantation.9,12
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Discussion
Dr G. Alexander Patterson (St Louis, Mo). Primary graft dys-
function (PGD), or what we used to refer to by a number of other
terms, such as reperfusion injury or reimplantation pulmonary
edema, is a common problem in lung transplantation. This has
been demonstrated to us once again today. It has been the focus of
more than 2 decades of research and clinical investigation. The
transplantation community has learned a lot in recent years regard-
ing the molecular pathogenesis of this problem, and we have
developed some very effective strategies to treat it and to lessen its
likelihood.
The International Society for Heart and Lung Transplantation
Pulmonary Council Working Group, under the direction of Dirk
Van Raemdonck and Jason Christie, have developed and will soon
publish in the Journal of Heart and Lung Transplantation a
standardized definition of PGD, which was referred to here today.
This report by the Minnesota group is an effort to use the new
definition to identify risk factors for the development of PGD.
I have a couple of questions. I do not know that you referred to
this specifically in your presentation, but in the article you elimi-
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comment in your article about radiographic infiltrates. Can you
explain why that is?
Dr Whitson. Well, that is used in the ISHLT criteria. In our
analysis, or at least when the data were initially collected, the chest
radiographic reports were not initially looked at. We reviewed a
small number of patients who had a P/F ratio that was greater than
300 and looked at their infiltrates, and looking at the outcomes for
their long-term survival, whether it was by grade 0 or grade 1, it
did not seem to have a difference, and therefore we lumped them
together, partly because those data had not been collected, looking
back at it. When we looked at the survival, both short-term and
long-term survival, their stratification is on whether they did or did
not have grade 3 PGD, and the chest radiograph was not included
in the grade 3 definition. Therefore we did not go back and pull
those.
Dr Patterson. You have demonstrated quite clearly that the
incidence of reperfusion injury or PGD is decreasing over time.
There is a clear difference in your own experience with respect to
its incidence in the former era and the more recent era. Surely that
has to be a surrogate marker for technical changes. Can you make
any specific comments about your perfusion strategy or your flush
strategy, your inflation strategy, and how that has changed in those
2 intervals of time?
Dr Whitson. Over those 13 years, we have essentially kept the
technical aspects the same. We have used antegrade perfusion. In
2001, we switched from Euro-Collins to Perfadex for the perfusion
solution.
Dr Patterson. Do you not use retrograde flush in your preser-
vation strategy?
Dr Whitson. No.
Dr Patterson. The other question I have—and I am not a
statistician— but you have examined many possible risk factors,
both donor and recipient risk factors. Close to 30 separate risk
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are going to identify something that is significant and predic-
tive. Specifically with regard to cardiopulmonary bypass, it
seems to me that your use of cardiopulmonary bypass is really
quite high, certainly higher than it is in our own institution,
particularly because you use a single-lung transplantation as an
operative strategy in quite a few, in almost half of your patients
or perhaps more, and therefore it is not clear to me whether
cardiopulmonary bypass is actually a risk factor or whether it is
a result. In our program we use cardiopulmonary bypass most
frequently when we have failure of the initial graft, and there-
fore we have already got graft dysfunction before bypass is
used. Can you comment?
Dr Whitson. You are correct that the more risk factors that are
analyzed the more likely it is that a type I error will be made. We
only analyzed risk factors that made sense clinically, and reason-
able arguments can be made for why each of those significant in
the multivariate analysis could cause early graft dysfunction. By-
pass was used in 12% of single lung procedures and in 60% of
bilateral single transplants. The usual indications were significant
adhesions or pulmonary hypertension and to some extent surgeon
preference, especially in the bilateral transplants.
Dr R. Duane Davis, Jr (Durham, NC). I want to follow up a
little bit on what Alec had asked you. Does your group have a
strategy for the reperfusion of the recipient, or is it just kind of
unclamp and go?
Dr Whitson. Thank you, Dr Davis. We avoid using 100%
FIO2 and high inspiratory tidal volumes when reinflating the
lung. More recently, we have used beta blockade in selective
circumstances to limit unnecessarily high cardiac outputs. If
patients are on cardiopulmonary bypass, we let the heart fill
slowly and cut back the flow rate over a 10-minute period. As
for the clamps, they are released gradually over a 5- to 10-
minute period.
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